DE1617791A1 - Verfahren zur Herstellung von Mitteln zur Behandlung von Knochenerkrankungen traumatischer oder medizinischer Art - Google Patents
Verfahren zur Herstellung von Mitteln zur Behandlung von Knochenerkrankungen traumatischer oder medizinischer ArtInfo
- Publication number
- DE1617791A1 DE1617791A1 DE19661617791 DE1617791A DE1617791A1 DE 1617791 A1 DE1617791 A1 DE 1617791A1 DE 19661617791 DE19661617791 DE 19661617791 DE 1617791 A DE1617791 A DE 1617791A DE 1617791 A1 DE1617791 A1 DE 1617791A1
- Authority
- DE
- Germany
- Prior art keywords
- extraction
- traumatic
- agents
- treatment
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 11
- 208000020084 Bone disease Diseases 0.000 title claims description 4
- 230000000472 traumatic effect Effects 0.000 title claims description 4
- 238000004519 manufacturing process Methods 0.000 title description 2
- 239000000047 product Substances 0.000 claims description 19
- 210000000988 bone and bone Anatomy 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000007791 liquid phase Substances 0.000 claims description 4
- 239000002609 medium Substances 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 3
- 239000012736 aqueous medium Substances 0.000 claims description 3
- 210000000845 cartilage Anatomy 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 210000003754 fetus Anatomy 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- 230000002378 acidificating effect Effects 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 8
- 230000035876 healing Effects 0.000 description 8
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 238000001574 biopsy Methods 0.000 description 6
- 206010017076 Fracture Diseases 0.000 description 5
- 238000004820 blood count Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 208000010392 Bone Fractures Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000037390 scarring Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000002188 osteogenic effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010031240 Osteodystrophy Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000002607 Pseudarthrosis Diseases 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 210000002758 humerus Anatomy 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035802 rapid maturation Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR22123A FR4683M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1965-06-24 | 1965-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1617791A1 true DE1617791A1 (de) | 1971-04-08 |
Family
ID=8582977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19661617791 Pending DE1617791A1 (de) | 1965-06-24 | 1966-06-24 | Verfahren zur Herstellung von Mitteln zur Behandlung von Knochenerkrankungen traumatischer oder medizinischer Art |
Country Status (5)
-
1965
- 1965-06-24 FR FR22123A patent/FR4683M/fr not_active Expired
-
1966
- 1966-06-17 BE BE682690D patent/BE682690A/xx unknown
- 1966-06-22 NL NL6608656A patent/NL6608656A/xx unknown
- 1966-06-24 DE DE19661617791 patent/DE1617791A1/de active Pending
- 1966-06-24 GB GB28516/66A patent/GB1146486A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1146486A (en) | 1969-03-26 |
| FR4683M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1966-12-19 |
| NL6608656A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1966-12-27 |
| BE682690A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1966-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3712767C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE69524624T2 (de) | Saponinzubereitungen und deren verwendung in iscoms | |
| DE69103755T2 (de) | Wachstumshormonkristalle und verfahren zu deren herstellung. | |
| DE69809175T2 (de) | Flavanon-enthaltende Zusammensetzungen | |
| DE3626414C2 (de) | Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel | |
| DE68911693T2 (de) | Pharmazeutisches mittel für behandlung von menschlichem krebs und verfahren zu seiner herstellung. | |
| Lassek | The pyramidal tract: a study of retrograde degeneration in the monkey | |
| DE1198489B (de) | Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie | |
| DE1076888B (de) | Verfahren zur Gewinnung atmungsfoerdernder Wirkstoffe fuer therapeutische Zwecke | |
| DE1620629C3 (de) | Verwendung eines Salzes von 2-Merkaptoäthansulf onsäure zur Herstellung von Mukolytica | |
| DE1467750C3 (de) | Verfahren zum Gewinnen von wertvollen Bestandteilen aus Pollen | |
| Reiter et al. | Behaviour and leg weakness in different broiler breeds | |
| DE1617791A1 (de) | Verfahren zur Herstellung von Mitteln zur Behandlung von Knochenerkrankungen traumatischer oder medizinischer Art | |
| DE1176317B (de) | Verfahren zur Herstellung von fuer Impf-zwecke geeigneten waessrigen Fluessigkeiten mit Tollwut-Virus | |
| DE3524794A1 (de) | Pharmazeutisches praeparat enthaltend lebende vermehrungsfaehige embryonalzellen, verfahren zu dessen herstellung und testverfahren zur bestimmung der pharmazeutischen wirksamkeit | |
| DE69006741T2 (de) | Reines protein und bioaktive pharmazeutische produkte. | |
| DE69021210T2 (de) | Vogel-Interleukin-2 zur Wachstumssteigerung von Vögeln. | |
| DE1924715A1 (de) | Arzneipraeparate zur Behandlung des Bandscheibenvorfalles | |
| AT225351B (de) | Verfahren zur Gewinnung organspezifischer Wirkstoffe fermentartiger Aktivität | |
| DE69433472T2 (de) | Recognin-vakzine | |
| DE10255481A1 (de) | Pharmazeutische Zubereitungen umfassend mittels Extraktion mit überkritischen Flüssigkeiten hergestellte Hopfenextrakte zur Verwendung als Sedativa | |
| DE3485773T2 (de) | Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten. | |
| DE556735C (de) | Verfahren zur Herstellung eines das Wachstum von Geschwuelsten hemmenden Stoffes | |
| DE69825433T2 (de) | Aktive substanz für inhibierung von tumoröse proliferation im geweben aus der ektoderm | |
| DE723019C (de) | Verfahren zur Herstellung einer wundenheilenden Zubereitung aus Embryonalstoffen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHJ | Non-payment of the annual fee |